Skip to Main content Skip to Navigation
Journal articles

Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype

Lou Grangeon 1, 2 David Wallon 3, 2 Camille Charbonnier 2 Olivier Quenez 2 Anne-Claire Richard 2 Stéphane Rousseau 2 Clara Budowski 2 Thibaud Lebouvier 4 Anne-Gaëlle Corbillé 5 Marie Vidailhet 6 Aurélie Méneret 6 Emmanuel Roze 6 Mathieu Anheim 7, 8 Christine Tranchant 7, 8 Pascal Favrole 9 Jean-Christophe Antoine 10 Luc Defebvre 11, 4 Xavier Ayrignac 12 Pierre Labauge 2 Jérémie Pariente 13 Michel Clanet 14 David Maltête 15 Anne Rovelet-Lecrux 15 Anne Boland 16 Jean-François Deleuze 17 Thierry Frebourg 2 Didier Hannequin 18, 2 Dominique Campion 19, 2 Gaël Nicolas 1, 2
1 UNIROUEN UFR Santé - UNIROUEN - UFR Santé
2 GPMCND - Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques
3 CHU Rouen
4 Département de neurologie[Lille]
5 Service de neurologie [Nantes]
6 ICM - Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute
7 FMTS - Fédération de Médecine Translationnelle de Strasbourg
8 IGBMC - Institut de Génétique et de Biologie Moléculaire et Cellulaire
9 Service de Neurologie [Aix-en-Provence]
10 Service de neurologie [CHU de Saint-Étienne]
11 LNFP - Laboratoire de Neurosciences Fonctionnelles et Pathologies
12 Département de neurologie [Montpellier]
13 Neurologie Vasculaire [Toulouse]
14 Hôpital Purpan [Toulouse]
15 DC2N - Différenciation et communication neuronale et neuroendocrine
16 JACOB - Institut de Biologie François JACOB
17 CNG - Centre National de Génotypage
18 Service de neurologie [Rouen]
19 Service de neurologie [Rouen]
Abstract : Primary familial brain calcification (PFBC) is a rare neurogenetic disorder with diverse neuropsychiatric expression. Mutations in four genes cause autosomal dominant PFBC: SLC20A2, XPR1, PDGFB and PDGFRB. Recently, biallelic mutations in the MYORG gene have been reported to cause PFBC with an autosomal recessive pattern of inheritance. We screened MYORG in 29 unrelated probands negatively screened for the autosomal dominant PFBC genes and identified 11 families with a biallelic rare or novel predicted damaging variant. We studied the clinical and radiological features of 16 patients of these 11 families and compared them to that of 102 autosomal dominant PFBC patients carrying a mutation in one of the four known autosomal dominant PFBC genes. We found that MYORG patients exhibited a high clinical penetrance with a median age of onset of 52 years (range: 21–62) with motor impairment at the forefront. In particular, dysarthria was the presenting sign in 11/16 patients. In contrast to patients with autosomal dominant PFBC, 12/15 (80%) symptomatic patients eventually presented at least four of the following five symptoms: dysarthria, cerebellar syndrome, gait disorder of any origin, akinetic-hypertonic syndrome and pyramidal signs. In addition to the most severe clinical pattern, MYORG patients exhibited the most severe pattern of calcifications as compared to the patients from the four autosomal dominant PFBC gene categories. Strikingly, 12/15 presented with brainstem calcifications in addition to extensive calcifications in other brain areas (lenticular nuclei, thalamus, cerebellar hemispheres, vermis, ±cortex). Among them, eight patients exhibited pontine calcifications, which were observed in none of the autosomal dominant PFBC patients and hence appeared to be highly specific. Finally, all patients exhibited cerebellar atrophy with diverse degrees of severity on CT scans. We confirmed the existence of cerebellar atrophy by performing MRI voxel-based morphometry analyses of MYORG patients with autosomal dominant PFBC mutation carriers as a comparison group. Of note, in three families, the father carried small pallido-dentate calcifications while carrying the mutation at the heterozygous state, suggesting a putative phenotypic expression in some heterozygous carriers. In conclusion, we confirm that MYORG is a novel major PFBC causative gene and that the phenotype associated with such mutations may be recognized based on pedigree, clinical and radiological features.
Document type :
Journal articles
Complete list of metadatas
https://hal-normandie-univ.archives-ouvertes.fr/hal-02538301
Contributor : Nathalie Porchet <>
Submitted on : Thursday, April 9, 2020 - 12:36:34 PM
Last modification on : Wednesday, December 9, 2020 - 10:52:17 AM

Identifiers

Collections

COMUE-NORMANDIE | UNIV-TLSE3 | IGBMC | CEA | ICM | UNIV-MONTPELLIER | JACOB | CEA-DRF | UNIV-NANTES | UNIROUEN | SORBONNE-UNIVERSITE | SU-MEDECINE | GPMCND | CNRS | SITE-ALSACE | UNIV-PARIS | DC2N

Citation

Lou Grangeon, David Wallon, Camille Charbonnier, Olivier Quenez, Anne-Claire Richard, et al.. Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype. Brain - A Journal of Neurology , Oxford University Press (OUP), 2019, 142 (6), pp.1573-1586. ⟨10.1093/brain/awz095⟩. ⟨hal-02538301⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

133